Prothena Reports First Quarter Financial Results
May 14, 2013 16:05 ET
|
Prothena Corporation plc
DUBLIN, Ireland, May 14, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc. (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the...
First Patient Dosed in Phase I Study of Prothena's Therapeutic Antibody for Treatment of AL Amyloidosis
April 23, 2013 16:05 ET
|
Prothena Corporation plc
DUBLIN, Ireland, April 23, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the...
Prothena Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Research and Development Update
March 28, 2013 16:05 ET
|
Prothena Corporation plc
Company Advances Pipeline With Strong Capital Position Following 2012 Spin-Off
NEOD001 to Enter Clinic in Early 2013
DUBLIN, Ireland, March 28, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc...
Prothena Announces Appointments of Chief Medical Officer and Chief Financial Officer
March 25, 2013 16:30 ET
|
Prothena Corporation plc
DUBLIN, Ireland, March 25, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena to Report Fourth Quarter and Full Year 2012 Financial Results and Host Webcast and Conference Call on March 28, 2013
March 21, 2013 16:05 ET
|
Prothena Corporation plc
DUBLIN, Ireland, March 21, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena Achieves Orphan Drug Status in EU for Lead Program NEOD001
February 27, 2013 16:30 ET
|
Prothena Corporation plc
DUBLIN, Ireland, Feb. 27, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena to Ring NASDAQ Stock Market Opening Bell
February 13, 2013 06:00 ET
|
Prothena Corporation plc
DUBLIN, Ireland, Feb. 13, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena Announces Addition of Industry Veterans to Board of Directors
January 07, 2013 08:00 ET
|
Prothena Corporation plc
DUBLIN, Ireland, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Prothena Begins Trading on NASDAQ Global Market Under Symbol "PRTA"
December 21, 2012 01:30 ET
|
Prothena Corporation plc
DUBLIN, Ireland, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...